Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 5,664 | 7,270 | 4,538 | 5,426 | 2,967 |
| Operating Income | -5,664 | -7,270 | -4,538 | -5,426 | -2,967 |
| Interest Expense | 0 | 0 | 0 | 0 | -497 |
| Other Income | 60 | 102 | 99 | -4,487 | -12 |
| Pre-tax Income | -5,604 | -7,168 | -4,439 | -9,913 | -2,482 |
| Income Tax | N/A | N/A | N/A | N/A | -154 |
| Net Income Continuous | -5,604 | -7,168 | -4,439 | -9,913 | -2,328 |
| Net Income | $-5,604 | $-7,168 | $-4,439 | $-9,913 | $-2,328 |
| EPS Basic Total Ops | -31.17 | -60.80 | -38.40 | -121.60 | 0.00 |
| EPS Basic Continuous Ops | -31.43 | -61.83 | -38.29 | -120.44 | -2.41 |
| EPS Diluted Total Ops | -31.17 | -60.80 | -38.40 | -121.60 | 0.00 |
| EPS Diluted Continuous Ops | -31.43 | -61.83 | -38.29 | -120.44 | -2.41 |
| EBITDA(a) | $-5,453 | $-7,242 | $-4,517 | $-5,405 | $-2,947 |